The economic burden of non-influenza-related viral respiratory tract infection in the United States.

By A. Fendrick, A. Monto, B. Nightengale, M. Sarnes. Archives of Internal Medicine, 2003

812 citations recorded by the source corpus.

Subfields: Emergency Medical Services, Epidemiology

View Paper: https://www.semanticscholar.org/paper/44f3c698f969188ac3177902631bacef1aed3eb7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. T. Walsh
2. A. Iwasaki

Citations in the corpus

• Complementary and alternative medicine use among adults: United States, 2002. (2004, result): “adult population (35) and is consistent with the observation that 40.”
• Virus Entry by Endocytosis (2013, neutral): “e �rst includes both in�uenza A and B viruses, while another is comprised of in�uenza C virus [1].”
• Seasonality of Respiratory Viral Infections. (2020, background): “Estimated costs in the United States for the common cold are $40 billion per year (2) and over $87 billion per year for influenza (3).”
• Human Rhinoviruses (2013, background): “households, the economic impact of non-influenza virus respiratory tract infections was estimated to be $40 billion annually in direct and indirect costs (4).”